Sort
130,381 grants matching “hiv”
Vaccines to Induce Functional Antibodies Targeting the V2 Loop
$899,104Susan B Zolla-Pazner · New York University School Of Medicine · P01 · FY2015 · AI
Subingual-parenteral Vaccination to Prevent Oral HIV Transmission in Infants
$899,083Kristina Abel · Univ Of North Carolina Chapel Hill · R01 · FY2019 · DE
Retrovirus Evolution and Cancer
$899,061John M Coffin · Tufts University Boston · R35 · FY2020 · CA
DOMINANCE IN T CELL RESPONSES TO SMALLPOX VACCINATION
$898,982Alessandro Sette · La Jolla Institute For Immunology · R01 · FY2006 · AI
TOPICAL MICROBICIDES &BIOLOGY OF VENEREAL PATHOGENS
$898,974University Of Texas Medical Br Galveston · P01 · FY2003 · AI
Humoral Responses
$898,908Guido Ferrari · Wistar Institute · U19 · FY2017 · AI
Modeling Combination Immunotherapy for HIV Cure in Humanized Mouse Models
$898,849James L Riley · University Of Pennsylvania · U19 · FY2024 · AI
Mechanisms of Viral Pathogenesis in the Central Nervous System
$898,826Karin Peterson · National Institute Of Allergy And Infectious Diseases · ZIA · FY2016 · AI
PS12-1201 COMPREHENSIVE HIV PREVENTION PROJECT FOR HEALTH DEPTS
$898,743Susan A Jones · Alaska State Department Of Hlth-Soc Svcs · U62 · FY2015 · PS
Identifying socioecological profiles that impact changes in care outcomes among Black Sexual minority men living with HIV
$898,737Derek Tramel Dangerfield II · George Washington University · UG3 · FY2023 · MH
iCyt Reflection Cell Sorter
$898,724Susan M Kaech · Yale University · S10 · FY2010 · RR
Clinical investigation of topical delivery of a muscarinic receptor antagonist for the prevention of chemotherapy-induced peripheral neuropathy
$898,634Angela Hansen · Winsantor, Inc. · R44 · FY2022 · CA
Industrialization of Antibody-based Contraceptive MPTs
$898,613Kevin John Whaley · Boston University Medical Campus · P50 · FY2021 · HD
Novel Model for HIV Latency in Primary Memory T Cells
$898,608Eric M Verdin · J. David Gladstone Institutes · DP1 · FY2013 · DA
Metropolitan Trajectories of HIV Epidemics, Drug Use, and Responses in US Key Populations
$898,575Hannah L Cooper · Emory University · R01 · FY2015 · DA
Promoting Sustained Viral Suppression Through Implementation of an Adapted Evidence-Informed Low-Barrier Care Model in a System of HIV Primary Care Clinics
$898,554Dennis Henyee Li · Northwestern University At Chicago · R01 · FY2022 · MH
ZAIMARA: Zambian Informed Motivated Aware and Responsible Adolescents and Adults
$898,514Carolyn Bolton Moore · Centre For Infectious Disease Research · UG1 · FY2025 · HD
East Africa IEDEA Regional Consortium
$898,487Constantin T Yiannoutsos · Indiana Univ-Purdue Univ At Indianapolis · U01 · FY2006 · AI
PrEP and dPEP: Doxycycline post-exposure prophylaxis for prevention of sexually transmitted infections among Kenyan women using HIV pre-exposure prophylaxis
$898,475Jared Baeten · University Of Washington · R01 · FY2023 · AI
Building 41 Flow Cytometry Core
$898,346Katherine McKinnon · Division Of Basic Sciences - Nci · ZIC · FY2025 · CA
Structure, Dynamics and Activation Mechanisms of Chemokine Receptors
$898,340Tracy M Handel · University Of California, San Diego · U01 · FY2014 · GM
Structure, Dynamics and Activation Mechanisms of Chemokine Receptors
$898,335Tracy M Handel · University Of California, San Diego · U01 · FY2012 · GM
HIV Exposed Uninfected Infant Cohort Study
$898,333Donald M Thea · Boston University Medical Campus · R01 · FY2022 · HD
Impact of concurrent HIV and latent TB therapies on Mtb-specific immune function
$898,189Deepak Kaushal · Texas Biomedical Research Institute · R01 · FY2020 · AI
Evolutionary lead optimization for immunotherapy of Marburg & Ebola viruses
$898,140Emmett Vance Schmidt · Massachusetts General Hospital · U01 · FY2008 · AI